Evidence map›Paper›PMID 31418169›Full record

ReviewEMBO reports2019

Metabolic implications of organelle-mitochondria communication.

Isabel Gordaliza-Alaguero, Carlos Cantó, Antonio Zorzano

Abstract readReview
In one paragraph

Review in EMBO reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Tools and Technologies for Studying Cancer Metabolism.Cancer treatment and research · 2026
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. HThe Journal of biological chemistry · 2025
    Article
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Isabel Gordaliza-AlagueroInstitute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.ORCID 0000-0002-1234-819X
Carlos CantóNestle Institute of Health Sciences (NIHS), Lausanne, Switzerland.
Antonio ZorzanoInstitute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.ORCID 0000-0002-1638-0306

Funding

CIBERDEMFundació Marató TV3Fundacion BBVAFundacion Ramon ArecesGovernment of Catalonia | Departament de Salut, Generalitat de Catalunya 2017SGR1015MEC | Instituto de Salud Carlos III (ISCIII) PIE-14/00045Ministerio de Economía y Competitividad (MEC) SAF2016-75246R
6 · The paper itself

Abstract

Cellular organelles are not static but show dynamism-a property that is likely relevant for their function. In addition, they interact with other organelles in a highly dynamic manner. In this review, we analyze the proteins involved in the interaction between mitochondria and other cellular organelles, especially the endoplasmic reticulum, lipid droplets, and lysosomes. Recent results indicate that, on one hand, metabolic alterations perturb the interaction between mitochondria and other organelles, and, on the other hand, that deficiency in proteins involved in the tethering between mitochondria and the ER or in specific functions of the interaction leads to metabolic alterations in a variety of tissues. The interaction between organelles is an emerging field that will permit to identify key proteins, to delineate novel modulation pathways, and to elucidate their implications in human disease.

Indexed as

AnimalsEndoplasmic ReticulumHumansLipid DropletsLipid MetabolismLysosomesMitochondriacontact sitesdiabetesendoplasmic reticuluminsulin resistancelipid droplets

Identifiers

PMID31418169
PMCPMC6726909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.